What is Franklin Templeton, Inc.'s earnings per share (EPS)?

Franklin Templeton, Inc. (BEN) reported diluted earnings per share of $0.91 for fiscal year 2025. This represents a 7.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Franklin Templeton, Inc. (BEN) Financials

BEN

FY2025 annual

Revenue $8.8B +3.5% YoY

Net Income $524.9M +12.9% YoY

EPS (Diluted) $0.91 +7.1% YoY

Free Cash Flow $911.6M +14.8% YoY

Market Cap $16.5B as of Oct 8, 2026

Price / Sales 1.8x on $9.3B revenue, trailing 12 months to June 30, 2026

Price / Earnings 20.3x on $812.8M net income, trailing 12 months to June 30, 2026

Price / Book 1.4x on $11.7B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Jul 31, 2026 Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BEN SEC filings page.

Franklin Templeton, Inc. (BEN) reported $8.8B in revenue for fiscal year 2025, up 3.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BEN FY2025 2026-10-03

Revenue has recovered, but operating profit remains far below FY2021 as a larger expense base absorbs much of the business.

By FY2025, revenue had returned above FY2021's level, yet operating profit was only $604M versus $1.9B then. That gap means the recovery is mainly top-line; prior profitability has not returned, consistent with a business whose cost structure or revenue mix now converts less activity into profit.

The FY2024 trough in operating margin partially reversed in FY2025, reaching 6.9% from 4.8%. It remains well below FY2021's 22.3%, making this a partial margin recovery without full operating leverage: higher revenue is reaching profit, but much less efficiently than before.

Since FY2022, operating cash flow has exceeded net income, and in FY2025 it was $1.1B against $525M of profit; free cash flow also remained positive after capital spending. Meanwhile, debt-to-equity declined from 0.3x in FY2021 to 0.2x in FY2025, making the financing posture less debt-dependent even as profitability rebuilds.

Financial Health Signals

Financial Health Score 46/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Franklin Templeton, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Franklin Templeton, Inc. has an operating margin of 6.9%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 57/100, indicating healthy but not exceptional operating efficiency. This is up from 4.8% the prior year.

Growth

Franklin Templeton, Inc.'s revenue grew a modest 3.5% year-over-year to $8.8B. This slow but positive growth earns a score of 53/100.

Leverage

Franklin Templeton, Inc. carries a low D/E ratio of 0.20, meaning only $0.20 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Not available for Franklin Templeton, Inc., and counted as zero in the overall score.

Cash Flow

Franklin Templeton, Inc. converts 10.4% of revenue into free cash flow ($911.6M). This strong cash generation earns a score of 67/100.

Returns

Not available for Franklin Templeton, Inc., and counted as zero in the overall score.

Piotroski F-Score Partial

7/7

Franklin Templeton, Inc. passes 7 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.03x

For every $1 of reported earnings, Franklin Templeton, Inc. generates $2.03 in operating cash flow ($1.1B OCF vs $524.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

6.37x

Franklin Templeton, Inc. earns $6.37 in operating income for every $1 of interest expense ($604.1M vs $94.9M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.4B

YoY+14.3%

QoQ+2.8%

5Y CAGR+1.7%

10Y CAGR+3.7%

Franklin Templeton, Inc. generated $2.4B in revenue in Q3 2026. This represents an increase of 14.3% from the same quarter a year earlier. Against the prior quarter it is up 2.8%.

EBITDA

$247.9M

YoY+32.1%

QoQ-29.7%

5Y CAGR-13.2%

Franklin Templeton, Inc.'s EBITDA was $247.9M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 32.1% from the same quarter a year earlier. Against the prior quarter it is down 29.7%.

Net Income

$171.5M

YoY+85.8%

QoQ-36.1%

5Y CAGR-17.1%

10Y CAGR-9.1%

Franklin Templeton, Inc. reported $171.5M in net income in Q3 2026. This represents an increase of 85.8% from the same quarter a year earlier. Against the prior quarter it is down 36.1%.

EPS (Diluted)

$0.31

YoY+106.7%

QoQ-36.7%

5Y CAGR-18.5%

10Y CAGR-8.7%

Franklin Templeton, Inc. earned $0.31 per diluted share (EPS) in Q3 2026. This represents an increase of 106.7% from the same quarter a year earlier. Against the prior quarter it is down 36.7%.

Cash & Balance Sheet

Cash & Debt

$3.8B

YoY-5.0%

QoQ+5.4%

5Y CAGR-2.9%

10Y CAGR-7.5%

Franklin Templeton, Inc. held $3.8B in cash against $2.4B in long-term debt as of Q3 2026.

Dividends Per Share

$0.33

YoY+3.1%

QoQ0.0%

Franklin Templeton, Inc. paid $0.33 per share in dividends in Q3 2026. This represents an increase of 3.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

508M

YoY-2.1%

QoQ-2.2%

5Y CAGR+0.2%

10Y CAGR-1.2%

Franklin Templeton, Inc. had 508M shares outstanding in Q3 2026. This represents a decrease of 2.1% from the same quarter a year earlier. Against the prior quarter it is down 2.2%.

Free Cash Flow

Not reported for Q3 2026.

Margins & Returns

Operating Margin

9.2%

YoY+1.7pp

QoQ-4.9pp

5Y change-12.8pp

10Y change-27.3pp

Franklin Templeton, Inc.'s operating margin was 9.2% in Q3 2026, reflecting core business profitability. This is up 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.9 percentage points.

Net Margin

7.3%

YoY+2.8pp

QoQ-4.4pp

5Y change-12.9pp

10Y change-20.0pp

Franklin Templeton, Inc.'s net profit margin was 7.3% in Q3 2026, showing the share of revenue converted to profit. This is up 2.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.4 percentage points.

Return on Equity

1.5%

YoY+0.7pp

QoQ-0.8pp

5Y change-2.6pp

10Y change-2.3pp

Franklin Templeton, Inc.'s ROE was 1.5% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Gross Margin

Not reported for Q3 2026.

Capital Allocation

Share Buybacks

$345.8M

YoY+119.7%

QoQ+505.6%

5Y CAGR+50.1%

10Y CAGR+0.7%

Franklin Templeton, Inc. spent $345.8M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 119.7% from the same quarter a year earlier. Against the prior quarter it is up 505.6%.

R&D Spending

Not reported for Q3 2026.

Capital Expenditures

Not reported for Q3 2026.

BEN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BEN quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$9.3B	$8.8B+3.5%	$8.5B+8.0%	$7.8B-5.1%	$8.3B-1.8%	$8.4B+51.4%	$5.6B-3.6%	$5.8B-8.6%	$6.3B-1.1%	$6.4B-3.4%	$6.6B-16.7%	$7.9B-6.4%	$8.5B+6.3%	$8.0B+12.4%	$7.1B-0.5%	$7.1B
SG&A Expenses	$918.8M	$774.5M+10.1%	$703.3M+24.5%	$565.0M0.0%	$564.9M+5.2%	$537.2M+19.3%	$450.3M+15.0%	$391.4M+5.3%	$371.7M+15.4%	$322.2M-5.3%	$340.1M-2.4%	$348.5M-3.2%	$360.1M+15.5%	$311.8M+12.2%	$277.8M+19.7%	$232.1M
Operating Income	$905.5M	$604.1M+48.2%	$407.6M-63.0%	$1.1B-37.9%	$1.8B-5.4%	$1.9B+78.8%	$1.0B-28.5%	$1.5B-27.7%	$2.0B-10.4%	$2.3B-4.3%	$2.4B-21.9%	$3.0B-6.0%	$3.2B+10.3%	$2.9B+16.1%	$2.5B-5.4%	$2.7B
EBITDA	N/A	$729.4M+39.2%	$524.1M-56.6%	$1.2B-35.5%	$1.9B-4.3%	$2.0B+73.9%	$1.1B-27.3%	$1.5B-26.5%	$2.1B-10.4%	$2.3B-4.1%	$2.4B-21.3%	$3.1B-5.9%	$3.3B+10.2%	$3.0B+16.1%	$2.6B-5.4%	$2.7B
Interest Expense	$89.0M	$94.9M-2.4%	$97.2M-21.4%	$123.7M+26.0%	$98.2M+15.0%	$85.4M+155.7%	$33.4M+49.1%	$22.4M-51.6%	$46.3M-10.1%	$51.5M+3.2%	$49.9M+26.0%	$39.6M-16.5%	$47.4M+1.1%	$46.9M+27.8%	$36.7M-1.9%	$37.4M
Income Tax	$385.5M	$237.9M+10.5%	$215.3M-31.1%	$312.3M-21.2%	$396.2M+13.3%	$349.6M+51.5%	$230.8M-47.8%	$442.3M-70.0%	$1.5B+93.9%	$759.4M+2.3%	$742.1M-19.7%	$923.7M-7.4%	$997.9M+16.6%	$855.9M+12.2%	$762.7M-5.1%	$803.4M
Net Income	$812.8M	$524.9M+12.9%	$464.8M-47.3%	$882.8M-31.7%	$1.3B-29.5%	$1.8B+129.2%	$798.9M-33.2%	$1.2B+56.4%	$764.4M-54.9%	$1.7B-1.7%	$1.7B-15.2%	$2.0B-14.6%	$2.4B+10.9%	$2.2B+11.3%	$1.9B+0.4%	$1.9B
EPS (Basic)	N/A	$0.91+7.1%	$0.85-50.6%	$1.72-32.0%	$2.53-29.3%	$3.58+125.2%	$1.59-32.3%	$2.35+69.1%	$1.39-53.8%	$3.01+2.4%	$2.94-10.6%	$3.29-13.2%	$3.79+12.5%	$3.37+12.7%	$2.99+3.5%	$2.89
EPS (Diluted)	$1.47	$0.91+7.1%	$0.85-50.6%	$1.72-32.0%	$2.53-29.1%	$3.57+124.5%	$1.59-32.3%	$2.35+69.1%	$1.39-53.8%	$3.01+2.4%	$2.94-10.6%	$3.29-13.2%	$3.79+12.5%	$3.37	$2.98+3.8%	$2.87
Diluted Shares (Avg)	N/A	517M+1.4%	510M+4.0%	491M+0.3%	489M-0.3%	491M-0.4%	492M-2.4%	504M-6.3%	538M-3.8%	559M-4.2%	584M-5.1%	615M-1.6%	625M-1.4%	634M	643M-3.5%	666M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$2.4B+14.3%	$2.3B+8.7%	$2.3B+3.4%	$2.3B+6.0%	$2.1B-2.8%	$2.1B-1.9%	$2.3B+13.1%	$2.2B+11.3%
SG&A Expenses	$312.8M+70.3%	$187.6M+2.6%	$195.6M+5.6%	$222.8M+13.6%	$183.7M+2.0%	$182.8M-6.3%	$185.2M+40.3%	$196.1M+42.3%
Operating Income	$215.8M+40.0%	$323.3M+122.0%	$281.0M+28.3%	$85.4M+156.7%	$154.1M-30.7%	$145.6M+12.6%	$219.0M+6.1%	-$150.7M-144.5%
EBITDA	$247.9M+32.1%	$352.7M+100.3%	$309.8M+24.3%	$116.5M+196.5%	$187.6M-25.4%	$176.1M+9.3%	$249.2M+7.3%	-$120.7M-133.1%
Interest Expense	$23.5M-8.9%	$19.9M-4.3%	$20.4M-11.7%	$25.2M+0.8%	$25.8M+0.4%	$20.8M-24.9%	$23.1M+22.9%	$25.0M+2.5%
Income Tax	$115.6M+93.0%	$99.1M+218.6%	$105.0M+29.5%	$65.8M+592.6%	$59.9M-12.0%	$31.1M-50.5%	$81.1M+8.3%	$9.5M-87.3%
Net Income	$171.5M+85.8%	$268.2M+77.1%	$255.5M+56.2%	$117.6M+238.8%	$92.3M-47.0%	$151.4M+21.9%	$163.6M-34.9%	-$84.7M-128.7%
EPS (Basic)	$0.31+106.7%	$0.49+88.5%	$0.46+58.6%	$0.21+210.5%	$0.15-53.1%	$0.26+13.0%	$0.29-42.0%	-$0.19-132.8%
EPS (Diluted)	$0.31+106.7%	$0.49+88.5%	$0.46+58.6%	$0.21+216.7%	$0.15-53.1%	$0.26+13.0%	$0.29-42.0%	-$0.18-131.0%
Diluted Shares (Avg)	516M-0.1%	518M-0.3%	518M0.0%	N/A	517M-0.1%	520M+0.1%	518M+6.2%	N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

BEN Balance Sheet

BEN quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$32.4B-0.3%	$32.5B+7.8%	$30.1B+7.3%	$28.1B+16.1%	$24.2B+11.5%	$21.7B+49.2%	$14.5B+1.0%	$14.4B-18.0%	$17.5B+8.9%	$16.1B-1.5%	$16.3B-0.1%	$16.4B+6.3%	$15.4B+4.3%	$14.8B+7.1%	$13.8B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$7.6B
Cash & Equivalents	$3.6B-18.9%	$4.4B+0.1%	$4.4B-7.9%	$4.8B+2.9%	$4.6B+16.5%	$4.0B-35.7%	$6.2B-10.2%	$6.9B-21.0%	$8.7B+3.1%	$8.5B+1.4%	$8.4B+10.2%	$7.6B+20.1%	$6.3B+4.5%	$6.1B+16.4%	$5.2B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$991.0M
Accounts Receivable	$1.5B+4.2%	$1.5B+9.7%	$1.3B+6.6%	$1.3B-11.4%	$1.4B+15.8%	$1.2B+66.6%	$740.0M+0.9%	$733.7M-4.4%	$767.8M+2.9%	$746.4M-10.9%	$838.0M-11.8%	$950.0M-8.6%	$1.0B+22.2%	$850.2M+10.0%	$773.2M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$1.9B
Goodwill	$6.2B-0.1%	$6.2B+3.5%	$6.0B+3.9%	$5.8B+29.6%	$4.5B-1.0%	$4.5B+111.3%	$2.1B+18.7%	$1.8B+6.4%	$1.7B+1.6%	$1.7B0.0%	$1.7B-1.8%	$1.7B-0.6%	$1.7B+10.4%	$1.5B+0.3%	$1.5B
Total Liabilities	$18.2B+1.6%	$17.9B+8.2%	$16.5B+16.2%	$14.2B+24.6%	$11.4B+11.2%	$10.3B+225.0%	$3.2B+0.9%	$3.1B+17.9%	$2.7B-24.3%	$3.5B-7.2%	$3.8B-3.3%	$3.9B-14.7%	$4.6B-7.7%	$5.0B+6.7%	$4.7B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.3B
Non-Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$2.2B
Long-Term Debt	$2.4B-15.0%	$2.8B-8.9%	$3.1B-9.6%	$3.4B-0.7%	$3.4B+12.7%	$3.0B+332.9%	$696.9M+0.1%	$695.9M-33.4%	$1.0B-25.5%	$1.4B+3.9%	$1.3B+12.5%	$1.2B0.0%	$1.2B-23.5%	$1.6B-15.4%	$1.9B
Total Equity	$12.1B-3.4%	$12.5B+5.0%	$11.9B+3.9%	$11.5B+2.2%	$11.2B+11.0%	$10.1B+2.1%	$9.9B+0.1%	$9.9B-21.6%	$12.6B+5.7%	$11.9B+0.8%	$11.8B+2.2%	$11.6B+15.0%	$10.1B+9.5%	$9.2B+7.9%	$8.5B
Retained Earnings	$11.5B-3.5%	$11.9B-3.6%	$12.4B+2.7%	$12.0B+4.3%	$11.6B+10.3%	$10.5B+1.8%	$10.3B+0.7%	$10.2B-20.5%	$12.8B+5.1%	$12.2B+1.1%	$12.1B+4.0%	$11.6B+16.4%	$10.0B+10.5%	$9.0B+7.1%	$8.4B

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$36.2B+11.3%	$34.1B+6.6%	$32.5B+0.5%	$32.4B-0.3%	$32.6B-2.1%	$32.0B-2.8%	$32.4B+8.5%	$32.5B+7.8%
Cash & Equivalents	$3.8B-5.0%	$3.6B+0.8%	$3.5B-4.4%	$3.6B-18.9%	$4.0B-3.8%	$3.5B-14.2%	$3.6B-6.0%	$4.4B+0.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$1.6B-9.1%	$1.4B-1.9%	$1.4B+3.7%	$1.5B+4.2%	$1.7B+9.7%	$1.5B+0.2%	$1.4B-5.2%	$1.5B+9.7%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$6.3B+1.4%	$6.3B+1.6%	$6.3B+1.6%	$6.2B-0.1%	$6.2B+0.2%	$6.2B0.0%	$6.2B+3.0%	$6.2B+3.5%
Total Liabilities	$21.8B+20.6%	$19.5B+16.0%	$18.2B+6.5%	$18.2B+1.6%	$18.1B-1.3%	$16.8B-7.0%	$17.1B+5.6%	$17.9B+8.2%
Long-Term Debt	$2.4B-9.9%	$2.3B-15.6%	$2.4B-15.1%	$2.4B-15.0%	$2.7B-12.1%	$2.7B-12.2%	$2.8B-8.9%	$2.8B-8.9%
Total Equity	$11.7B-3.8%	$12.1B-1.8%	$12.1B-2.6%	$12.1B-3.4%	$12.2B-5.2%	$12.3B-4.0%	$12.5B+3.8%	$12.5B+5.0%
Retained Earnings	$11.5B-0.8%	$11.6B-1.4%	$11.5B-3.2%	$11.5B-3.5%	$11.6B-5.8%	$11.7B-4.4%	$11.9B-3.9%	$11.9B-3.6%

Not reported in any period shown, so not listed: Current Assets, Inventory, Current Liabilities, Non-Current Liabilities.

BEN Cash Flow Statement

BEN quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$277.8M	$1.1B+9.8%	$971.3M-10.8%	$1.1B-44.3%	$2.0B+57.1%	$1.2B+15.0%	$1.1B+303.5%	$268.5M-88.0%	$2.2B+96.4%	$1.1B-34.3%	$1.7B-23.3%	$2.3B+5.3%	$2.1B+5.0%	$2.0B+90.9%	$1.1B-34.3%	$1.6B
Depreciation & Amortization	N/A	$125.3M+7.6%	$116.5M+11.7%	$104.3M+8.9%	$95.8M+21.9%	$78.6M+5.5%	$74.5M-5.3%	$78.7M+5.5%	$74.6M-8.5%	$81.5M+0.6%	$81.0M-0.7%	$81.6M-1.2%	$82.6M+7.4%	$76.9M+13.3%	$67.9M-5.0%	$71.5M
Stock-Based Compensation	N/A	$214.8M-12.7%	$246.1M+34.8%	$182.6M-12.3%	$208.2M+21.1%	$171.9M+40.6%	$122.3M+9.7%	$111.5M-5.3%	$117.8M-4.5%	$123.4M-6.2%	$131.5M-6.1%	$140.0M+9.6%	$127.7M+12.6%	$113.4M+11.9%	$101.3M+14.2%	$88.7M
Capital Expenditures	N/A	$154.5M-12.8%	$177.1M+19.0%	$148.8M+64.8%	$90.3M+13.9%	$79.3M-23.5%	$103.7M-55.6%	$233.7M+119.4%	$106.5M+42.2%	$74.9M-23.3%	$97.6M+41.9%	$68.8M+29.6%	$53.1M-14.6%	$62.2M-20.7%	$78.4M-40.5%	$131.7M
Free Cash Flow	N/A	$911.6M+14.8%	$794.2M-15.5%	$940.4M-49.6%	$1.9B+60.1%	$1.2B+19.0%	$979.6M+2714.9%	$34.8M-98.4%	$2.1B+100.2%	$1.1B-34.9%	$1.6B-25.3%	$2.2B+4.7%	$2.1B+5.6%	$2.0B+99.8%	$987.8M-33.7%	$1.5B
Investing Cash Flow	-$3.8B	-$2.3B+3.3%	-$2.4B+32.9%	-$3.6B-8.4%	-$3.3B-27.3%	-$2.6B+35.6%	-$4.1B-218.5%	-$1.3B-339.2%	-$290.4M-658.5%	$52.0M-72.9%	$192.2M-22.8%	$248.9M-36.3%	$390.6M+67.7%	$232.9M-73.3%	$873.4M+100.4%	$435.9M
Financing Cash Flow	$3.3B	$452.4M-68.0%	$1.4B-32.8%	$2.1B+32.9%	$1.6B-21.9%	$2.0B+176.4%	$734.4M+116.1%	$339.9M+109.0%	-$3.8B-293.5%	-$956.0M+46.9%	-$1.8B-11.7%	-$1.6B-34.9%	-$1.2B+40.8%	-$2.0B-86.0%	-$1.1B-12.1%	-$968.2M
Dividends Paid	$693.9M	$683.7M+4.2%	$656.4M+8.1%	$607.3M+4.2%	$583.1M+4.2%	$559.7M+5.0%	$533.2M+2.8%	$518.6M-75.5%	$2.1B+379.8%	$441.2M+8.0%	$408.7M-38.7%	$666.4M+129.5%	$290.4M-67.1%	$882.7M+33.1%	$663.0M+206.5%	$216.3M
Share Buybacks	$511.9M	$240.3M-12.4%	$274.4M+7.1%	$256.3M+41.8%	$180.8M-13.2%	$208.2M-4.6%	$218.2M-71.1%	$754.5M-47.0%	$1.4B+86.2%	$765.3M-41.5%	$1.3B+23.4%	$1.1B+70.3%	$622.2M+26.7%	$491.0M-38.4%	$797.4M-16.4%	$954.2M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$581.2M-54.7%	-$27.6M+44.9%	-$255.1M-75.7%	-$20.7M-103.7%	$1.3B+142.6%	-$50.1M-136.7%	-$145.2M+42.4%	$558.2M-27.0%
Depreciation & Amortization	$32.1M-4.2%	$29.4M-3.6%	$28.8M-4.6%	$31.1M+3.7%	$33.5M+15.5%	$30.5M-4.1%	$30.2M+17.5%	$30.0M+15.4%
Stock-Based Compensation	N/A	N/A	$75.6M+3.3%	N/A	N/A	N/A	$73.2M+9.6%	N/A
Capital Expenditures	N/A	N/A	N/A	$31.2M-55.3%	$14.0M-69.6%	$37.5M-10.1%	$71.8M+268.2%	$69.8M+155.7%
Free Cash Flow	N/A	N/A	N/A	-$51.9M-110.6%	$1.3B+162.9%	-$87.6M-192.3%	-$217.0M+20.0%	$488.4M-33.7%
Investing Cash Flow	-$1.7B-88.6%	-$1.4B-273.2%	-$317.2M+51.7%	-$441.4M+63.2%	-$880.7M-8.5%	-$364.1M-33.3%	-$656.5M-377.1%	-$1.2B-261.6%
Financing Cash Flow	$1.3B+7871.3%	$1.5B+410.0%	$487.4M+454.5%	$88.5M-90.3%	-$16.4M-106.0%	$292.4M-25.2%	$87.9M+155.3%	$909.2M+335.6%
Dividends Paid	$176.2M+1.7%	$176.4M+1.8%	$170.2M+2.4%	$171.1M+2.4%	$173.2M+3.2%	$173.2M+4.5%	$166.2M+6.7%	$167.1M+9.6%
Share Buybacks	$345.8M+119.7%	$57.1M+471.0%	$41.9M+622.4%	$67.1M-34.5%	$157.4M+55.1%	$10.0M-14.5%	$5.8M-90.1%	$102.4M-45.0%

BEN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BEN quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	6.9%+2.1pp	4.8%-9.2pp	14.0%-7.4pp	21.4%-0.8pp	22.3%+3.4pp	18.8%-6.6pp	25.4%-6.7pp	32.1%-3.3pp	35.4%-0.3pp	35.8%-2.3pp	38.1%+0.2pp	37.9%+1.4pp	36.6%+1.2pp	35.4%-1.8pp	37.3%
Net Margin	6.0%+0.5pp	5.5%-5.8pp	11.3%-4.4pp	15.6%-6.1pp	21.7%+7.4pp	14.3%-6.4pp	20.7%+8.6pp	12.1%-14.4pp	26.5%+0.5pp	26.1%+0.5pp	25.6%-2.5pp	28.1%+1.2pp	26.9%-0.3pp	27.2%+0.3pp	26.9%
Return on Equity	4.3%+0.6pp	3.7%-3.7pp	7.4%-3.9pp	11.3%-5.1pp	16.3%+8.4pp	7.9%-4.2pp	12.1%+4.3pp	7.7%-5.7pp	13.4%-1.0pp	14.5%-2.7pp	17.2%-3.4pp	20.6%-0.8pp	21.3%+0.4pp	21.0%-1.6pp	22.6%
Return on Assets	1.6%+0.2pp	1.4%-1.5pp	2.9%-1.7pp	4.6%-3.0pp	7.6%+3.9pp	3.7%-4.5pp	8.2%+2.9pp	5.3%-4.4pp	9.7%-1.1pp	10.7%-1.7pp	12.5%-2.1pp	14.6%+0.6pp	14.0%+0.9pp	13.1%-0.9pp	14.0%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	5.81
Debt-to-Equity	0.200.0x	0.220.0x	0.260.0x	0.290.0x	0.300.0x	0.30+0.2x	0.070.0x	0.070.0x	0.080.0x	0.120.0x	0.110.0x	0.100.0x	0.12-0.1x	0.170.0x	0.22
Asset Turnover	0.270.0x	0.260.0x	0.260.0x	0.29-0.1x	0.35+0.1x	0.26-0.1x	0.400.0x	0.44+0.1x	0.360.0x	0.41-0.1x	0.490.0x	0.520.0x	0.520.0x	0.480.0x	0.52
FCF Margin	10.4%+1.0pp	9.4%-2.6pp	12.0%-10.6pp	22.6%+8.7pp	13.8%-3.8pp	17.6%+17.0pp	0.6%-33.0pp	33.6%+17.0pp	16.6%-8.0pp	24.6%-2.8pp	27.5%+2.9pp	24.6%-0.2pp	24.7%+10.8pp	13.9%-7.0pp	20.9%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Margin	9.2%+1.7pp	14.1%+7.2pp	12.1%+2.4pp	3.6%+10.5pp	7.5%-3.0pp	6.9%+0.9pp	9.7%-0.6pp	-6.8%-23.8pp
Net Margin	7.3%+2.8pp	11.7%+4.5pp	11.0%+3.7pp	5.0%+8.8pp	4.5%-3.7pp	7.2%+1.4pp	7.3%-5.4pp	-3.8%-18.7pp
Return on Equity	1.5%+0.7pp	2.2%+1.0pp	2.1%+0.8pp	1.0%+1.6pp	0.8%-0.6pp	1.2%+0.3pp	1.3%-0.8pp	-0.7%-3.2pp
Return on Assets	0.5%+0.2pp	0.8%+0.3pp	0.8%+0.3pp	0.4%+0.6pp	0.3%-0.2pp	0.5%+0.1pp	0.5%-0.3pp	-0.3%-1.2pp
Debt-to-Equity	0.200.0x	0.190.0x	0.190.0x	0.200.0x	0.220.0x	0.220.0x	0.220.0x	0.220.0x
Asset Turnover	0.070.0x	0.070.0x	0.070.0x	0.070.0x	0.060.0x	0.070.0x	0.070.0x	0.070.0x
FCF Margin	N/A	N/A	N/A	-2.2%-24.3pp	61.4%+38.7pp	-4.2%-8.6pp	-9.6%+4.0pp	22.1%-15.0pp

Not reported in any period shown, so not listed: Gross Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Franklin Templeton, Inc. BEN	FY2025	$8.8B	$524.9M	6.0%	$16.5B	46/100
Invesco LTD IVZ	FY2025	$6.4B	-$174.8M	-2.7%	$13.5B	41/100
Equitable Holdings, Inc. EQH	FY2025	$11.7B	-$1K	0.0%	$14.5B	13/100
SEI Investments Co SEIC	FY2025	$2.3B	$715.3M	31.1%	$12.3B	85/100
Ares Capital Corporation ARCC	FY2025	N/A	$1.3B	N/A	$13.2B	—
T Rowe Price Group Inc TROW	FY2025	$7.3B	$2.1B	28.5%	$22.2B	51/100

Where Franklin Templeton, Inc. Ranks

Frequently Asked Questions

What is Franklin Templeton, Inc.'s annual revenue?

Franklin Templeton, Inc. (BEN) reported $8.8B in total revenue for fiscal year 2025. This represents a 3.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Franklin Templeton, Inc.'s revenue growing?

Franklin Templeton, Inc. (BEN) revenue grew by 3.5% year-over-year, from $8.5B to $8.8B in fiscal year 2025.

Is Franklin Templeton, Inc. profitable?

Yes, Franklin Templeton, Inc. (BEN) reported a net income of $524.9M in fiscal year 2025, with a net profit margin of 6.0%.

What is Franklin Templeton, Inc.'s EBITDA?

Franklin Templeton, Inc. (BEN) had EBITDA of $729.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Franklin Templeton, Inc. have?

As of fiscal year 2025, Franklin Templeton, Inc. (BEN) had $3.6B in cash and equivalents against $2.4B in long-term debt.

What is Franklin Templeton, Inc.'s operating margin?

Franklin Templeton, Inc. (BEN) had an operating margin of 6.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Franklin Templeton, Inc.'s net profit margin?

Franklin Templeton, Inc. (BEN) had a net profit margin of 6.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Franklin Templeton, Inc. pay dividends?

Yes, Franklin Templeton, Inc. (BEN) paid $1.28 per share in dividends during fiscal year 2025.

What is Franklin Templeton, Inc.'s return on equity (ROE)?

Franklin Templeton, Inc. (BEN) has a return on equity of 4.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Franklin Templeton, Inc.'s free cash flow?

Franklin Templeton, Inc. (BEN) generated $911.6M in free cash flow during fiscal year 2025. This represents a 14.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Franklin Templeton, Inc.'s operating cash flow?

Franklin Templeton, Inc. (BEN) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Franklin Templeton, Inc.'s total assets?

Franklin Templeton, Inc. (BEN) had $32.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Franklin Templeton, Inc.'s capital expenditures?

Franklin Templeton, Inc. (BEN) invested $154.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Franklin Templeton, Inc. buy back shares?

Yes, Franklin Templeton, Inc. (BEN) spent $240.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Franklin Templeton, Inc. have outstanding?

Franklin Templeton, Inc. (BEN) had 521M shares outstanding as of fiscal year 2025.

What is Franklin Templeton, Inc.'s debt-to-equity ratio?

Franklin Templeton, Inc. (BEN) had a debt-to-equity ratio of 0.20 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Franklin Templeton, Inc.'s return on assets (ROA)?

Franklin Templeton, Inc. (BEN) had a return on assets of 1.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Franklin Templeton, Inc.'s P/E ratio?

Franklin Templeton, Inc. (BEN) trades at 20.3x earnings, its market capitalization divided by net income of $812.8M net income, trailing 12 months to June 30, 2026. The market capitalization is $16.5B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Franklin Templeton, Inc.'s price-to-sales ratio?

Franklin Templeton, Inc. (BEN) trades at 1.8x sales, its market capitalization divided by revenue of $9.3B revenue, trailing 12 months to June 30, 2026. The market capitalization is $16.5B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Franklin Templeton, Inc.'s Piotroski F-Score?

Franklin Templeton, Inc. (BEN) has a Piotroski F-Score of 7 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Franklin Templeton, Inc.'s earnings high quality?

Franklin Templeton, Inc. (BEN) has an earnings quality ratio of 2.03x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Franklin Templeton, Inc. cover its interest payments?

Franklin Templeton, Inc. (BEN) has an interest coverage ratio of 6.37x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Franklin Templeton, Inc.?

Franklin Templeton, Inc. (BEN) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.